Loading...
Amplifon S.p.A.
AMFPF•PNK
Healthcare
Medical - Distribution
$17.25
$-0.11(-0.63%)
Amplifon S.p.A. (AMFPF) Financial Performance & Income Statement Overview
Review Amplifon S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.60%
↑ 6.60%
Operating Income Growth
-3.23%
↓ 3.23%
Net Income Growth
-6.29%
↓ 6.29%
Operating Cash Flow Growth
8.66%
↑ 8.66%
Operating Margin
10.49%
↑ 10.49%
Gross Margin
56.44%
↑ 56.44%
Net Profit Margin
5.93%
↑ 5.93%
ROE
12.61%
↑ 12.61%
ROIC
8.98%
↑ 8.98%
Amplifon S.p.A. (AMFPF) Income Statement & Financial Overview
Review Amplifon S.p.A.'s (AMFPF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $587.79M | $664.40M | $572.74M | $604.14M |
| Cost of Revenue | $449.77M | -$296.77M | $453.54M | $446.99M |
| Gross Profit | $138.02M | $961.17M | $119.20M | $157.15M |
| Gross Profit Ratio | $0.23 | $1.45 | $0.21 | $0.26 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $886.75M | $0.00 | $0.00 |
| Operating Expenses | $76.58M | $886.75M | $79.66M | $72.83M |
| Total Costs & Expenses | $526.35M | $589.97M | $534.15M | $518.26M |
| Interest Income | $0.00 | $2.35M | $0.00 | $0.00 |
| Interest Expense | $13.38M | $17.78M | $15.29M | $12.50M |
| Depreciation & Amortization | $79.36M | $81.77M | $75.45M | $73.64M |
| EBITDA | $139.47M | $153.06M | $113.25M | $157.11M |
| EBITDA Ratio | $0.24 | $0.23 | $0.20 | $0.26 |
| Operating Income | $61.44M | $69.28M | $38.59M | $84.31M |
| Operating Income Ratio | $0.10 | $0.10 | $0.07 | $0.14 |
| Other Income/Expenses (Net) | -$14.71M | -$16.44M | -$16.09M | -$13.06M |
| Income Before Tax | $46.73M | $52.84M | $22.51M | $70.97M |
| Income Before Tax Ratio | $0.08 | $0.08 | $0.04 | $0.12 |
| Income Tax Expense | $13.80M | $11.58M | $6.07M | $18.71M |
| Net Income | $32.88M | $41.19M | $16.77M | $52.93M |
| Net Income Ratio | $0.06 | $0.06 | $0.03 | $0.09 |
| EPS | $0.15 | $0.18 | $0.07 | $0.23 |
| Diluted EPS | $0.15 | $0.18 | $0.07 | $0.23 |
| Weighted Avg Shares Outstanding | $225.25M | $225.14M | $225.69M | $226.18M |
| Weighted Avg Shares Outstanding (Diluted) | $226.39M | $225.14M | $227.02M | $228.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan